Aptamer Group PLC
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and … Read more
Aptamer Group PLC (APTA) - Net Assets
Latest net assets as of June 2025: GBX1.38 Million GBX
Based on the latest financial reports, Aptamer Group PLC (APTA) has net assets worth GBX1.38 Million GBX as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX2.83 Million) and total liabilities (GBX1.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX1.38 Million |
| % of Total Assets | 48.76% |
| Annual Growth Rate | 7.11% |
| 5-Year Change | 1216.19% |
| 10-Year Change | N/A |
| Growth Volatility | 2820.39 |
Aptamer Group PLC - Net Assets Trend (2019–2025)
This chart illustrates how Aptamer Group PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Aptamer Group PLC (2019–2025)
The table below shows the annual net assets of Aptamer Group PLC from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | GBX1.38 Million | +55.81% |
| 2024-06-30 | GBX887.00K | +191.78% |
| 2023-06-30 | GBX304.00K | -96.22% |
| 2022-06-30 | GBX8.05 Million | +7567.62% |
| 2021-06-30 | GBX105.00K | -57.28% |
| 2020-03-31 | GBX245.81K | -72.68% |
| 2019-03-31 | GBX899.87K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aptamer Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1245216100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX1.99 Million | 144.07% |
| Other Comprehensive Income | GBX619.00K | 44.79% |
| Other Components | GBX13.63 Million | 986.54% |
| Total Equity | GBX1.38 Million | 100.00% |
Aptamer Group PLC Competitors by Market Cap
The table below lists competitors of Aptamer Group PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HuaAn Zhangjiang Everbright Park
SHG:508000
|
$3.12K |
|
BETA GLASS PLC
XNSA:BETAGLAS
|
$3.12K |
|
Rebus Holdings Inc.
PINK:RBSH
|
$3.13K |
|
KLN
WAR:KLN
|
$3.13K |
|
Pakistan Aluminium Beverage Cans Ltd
KAR:PABC
|
$3.11K |
|
ADX
WAR:ADX
|
$3.11K |
|
Tortilla Mexican Grill PLC
LSE:MEX
|
$3.10K |
|
First Foods Group Inc
PINK:FIFG
|
$3.10K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aptamer Group PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 887,000 to 1,382,000, a change of 495,000 (55.8%).
- Net loss of 2,424,000 reduced equity.
- New share issuances of 2,891,000 increased equity.
- Other comprehensive income increased equity by 115,000.
- Other factors decreased equity by 87,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-2.42 Million | -175.4% |
| Share Issuances | GBX2.89 Million | +209.19% |
| Other Comprehensive Income | GBX115.00K | +8.32% |
| Other Changes | GBX-87.00K | -6.3% |
| Total Change | GBX- | 55.81% |
Book Value vs Market Value Analysis
This analysis compares Aptamer Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1070.78x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 63.21x to 1070.78x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | GBX0.01 | GBX0.83 | x |
| 2020-03-31 | GBX0.00 | GBX0.83 | x |
| 2021-06-30 | GBX0.00 | GBX0.83 | x |
| 2022-06-30 | GBX0.12 | GBX0.83 | x |
| 2023-06-30 | GBX0.00 | GBX0.83 | x |
| 2024-06-30 | GBX0.00 | GBX0.83 | x |
| 2025-06-30 | GBX0.00 | GBX0.83 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aptamer Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -175.40%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -201.50%
- • Asset Turnover: 0.42x
- • Equity Multiplier: 2.05x
- Recent ROE (-175.40%) is above the historical average (-742.73%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -50.56% | -46.11% | 0.71x | 1.55x | GBX-544.97K |
| 2020 | -274.50% | -78.96% | 0.61x | 5.65x | GBX-699.31K |
| 2021 | -1761.52% | -144.50% | 0.62x | 19.66x | GBX-1.86 Million |
| 2022 | -26.00% | -51.86% | 0.35x | 1.43x | GBX-2.90 Million |
| 2023 | -2577.63% | -447.26% | 0.64x | 9.06x | GBX-7.87 Million |
| 2024 | -333.48% | -343.95% | 0.31x | 3.12x | GBX-3.05 Million |
| 2025 | -175.40% | -201.50% | 0.42x | 2.05x | GBX-2.56 Million |
Industry Comparison
This section compares Aptamer Group PLC's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $11,113,250
- Average return on equity (ROE) among peers: -147.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aptamer Group PLC (APTA) | GBX1.38 Million | -50.56% | 1.05x | $3.12K |
| 4BASEBIO UK SOCIETAS (4BB) | $11.70 Million | -27.66% | 0.26x | $10.53K |
| Arecor Therapeutics PLC (AREC) | $773.79K | -355.70% | 4.54x | $3.33K |
| Bioventix (BVXP) | $4.20 Million | 36.18% | 0.07x | $9.85K |
| Cizzle Biotechnology Holdings PLC (CIZ) | $741.00K | -0.02% | 3.16x | $747.56 |
| Fusion Antibodies PLC (FAB) | $1.46 Million | 79.21% | 0.28x | $2.07K |
| Faron Pharmaceuticals Oy (FARN) | $1.61 Million | -823.73% | 5.34x | $27.00K |
| Futura Medical (FUM) | $9.72 Million | -50.98% | 0.21x | $424.60 |
| hVIVO plc (HVO) | $2.86 Million | -195.31% | 2.17x | $5.18K |
| International Biotechnology Trust plc (IBT) | $66.95 Million | 14.71% | 0.00x | $1.10K |